Showing 1,341 - 1,360 results of 8,597 for search 'effective dysfunction', query time: 0.12s Refine Results
  1. 1341
  2. 1342

    Suprachiasmatic nucleus dysfunction induces anxiety- and depression-like behaviors via activating the BDNF-TrkB pathway of the striatum by Xiaotao Liang, Yuewen Ding, Xiaoyu Zhu, Jing Qiu, Xiaoqin Shen, Yifan Xiong, Jieli Zhou, Xiaoshan Liang, Wei Xie

    Published 2025-03-01
    “…Microinjection of the TrkB inhibitor ANA-12 can effectively reverse anxiety- and depression-like behaviors. …”
    Get full text
    Article
  3. 1343

    Spectrofluorimetric determination of cyclic guanosine monophosphate in human nasal secretions: evaluating levels in healthy individuals and patients with olfactory dysfunction by Mohamed H. Abdelazim, Faisal Alsenani, Adnan Alharbi, Fahad H. Baali, Abdulaziz H. Baali, Maram H. Abduljabbar, Reem M. Alnemari, Majed A. Algarni

    Published 2025-06-01
    “…Abstract Cyclic guanosine monophosphate (cGMP) is a second messenger involved in olfactory signal transduction. cGMP levels modulate the sensitivity of olfactory neurons and are implicated in olfactory dysfunctions. Previous reports demonstrate that individuals with olfactory dysfunction exhibit lower cGMP levels in the nasal mucus, necessitating precise analytical quantitative methods. …”
    Get full text
    Article
  4. 1344

    MRI contrast accumulation in features of cerebral small vessel disease: blood-brain barrier dysfunction or elevated vascular density? by Tomas Vikner, Anders Garpebring, Cecilia Björnfot, Jan Malm, Anders Eklund, Anders Wåhlin

    Published 2025-07-01
    “…However, high contrast accumulation may mainly reflect high vascularization, and to a lesser degree than previously recognized BBB dysfunction.…”
    Get full text
    Article
  5. 1345

    Gustatory Dysfunction among a Sample of Depressed Egyptian Adults under Antidepressants Therapy: A Retrospective Cohort Study by Christine Mikhail, Khaled Elgaaly, Ahmed Abd El Latif Abd El Hamid, Olfat Shaker, Shereen Ali

    Published 2021-01-01
    “…It is quite clear that the ability to perceive taste sensations significantly affects food choice, which consequently affects health status in the long term. Gustatory dysfunction is a neglected symptom among the depressed patients and those under antidepressants therapy, although these patients are suspectable to oral problems, due to general self-negligence related to mental disease, fear of dental treatment, and side effects of varied medications utilized in psychiatry. …”
    Get full text
    Article
  6. 1346
  7. 1347

    MG53 deficiency mediated skeletal muscle dysfunction in chronic obstructive pulmonary disease via impairing mitochondrial fission by Liwei Liao, Ziwen Zheng, Mingming Deng, Weidong Xu, Qin Zhang, Zilin Wang, Chang Li, Jiaye Li, Yiding Bian, Kai Wang, Jinrui Miao, Ruixia Li, Yan Yin, Xiaoming Zhou, Gang Hou

    Published 2025-06-01
    “…The underlying mechanisms were investigated using multi-omics sequencing, live-cell imaging, and histological and molecular experiments. The effectiveness and safety of recombinant mitsugumin 53 in treating cigarette smoke-induced muscle dysfunction were evaluated in vitro and in vivo. …”
    Get full text
    Article
  8. 1348
  9. 1349

    Association between cardiovascular health and metabolic dysfunction-associated steatotic liver disease: a nationwide cross-sectional study by Lian-Zhen Huang, Ze-Bin Ni, Wei-Feng Huang, Li-Ping Sheng, Yan-Qing Wang, Jin-Yan Zhang

    Published 2025-01-01
    “…Abstract Purpose Evidence concerning the effect of cardiovascular health (CVH) on the risk of metabolic dysfunctional-associated steatotic liver disease (MASLD) is scarce. …”
    Get full text
    Article
  10. 1350

    Machine Learning-Based Non-Invasive Prediction of Metabolic Dysfunction-Associated Steatohepatitis in Obese Patients: A Retrospective Study by Jie Chen, Bo Zhang, Yong Cheng, Yuanchen Jia, Biao Zhou

    Published 2025-04-01
    “…<b>Objectives</b>: We aimed to develop and validate machine learning (ML) models that integrate clinical and laboratory data for the non-invasive prediction of metabolic dysfunction-associated steatohepatitis (MASH) in an obese population. …”
    Get full text
    Article
  11. 1351

    Comparative assessment of structural and tear film alterations in rabbit meibomian gland dysfunction models using chemical and electrocauterization techniques by Deeksha Prasad, Saumya Jakati, Kiran Kumar Bokara, Sayan Basu, Vivek Singh, Pragnya Rao Donthineni

    Published 2025-07-01
    “…Abstract Meibomian gland dysfunction (MGD) constitutes the most common cause of dry eye disease (DED), where altering meibum or lipids result in tear film instability. …”
    Get full text
    Article
  12. 1352
  13. 1353
  14. 1354

    Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab by A. V. Petrov, O. A. Pritulo, A. A. Petrov

    Published 2024-12-01
    “…Objective: a comparative evaluation of the effect of the interleukin-17A inhibitor (iIL) netakimab (NTK) and methotrexate (MTX) on laboratory markers of endothelial dysfunction in patients with psoriatic arthritis (PsA) in comparison with the dynamics of clinical efficacy indicators during 6 months of therapy.Material and methods. …”
    Get full text
    Article
  15. 1355

    Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases by Mengyun Xiao, Xianggeng Chi, Xiaohui Zhu, Zigan Xu, Yaoshuang Zou, Yue Peng, Shaodong Luan, Jingjing Dong, Yong Dai, Lianghong Yin

    Published 2024-08-01
    “…Future research should validate the complement-mitochondrial-EMT pathway axis and explore the effects and mechanisms of CFB inhibitors in alleviating ARKD progression.…”
    Get full text
    Article
  16. 1356

    Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers by O. A. Osipova, E. V. Gosteva, O. N. Belousova, S. G. Gorelik, N. I. Klyushnikov, Yu. A. Lykov, A. N. Khachaturov, V. V. Bukatov

    Published 2022-01-01
    “…Aim. To compare the effect of beta-blocker therapy (bisoprolol and nebivolol) on the dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke (IS).Material and methods. …”
    Get full text
    Article
  17. 1357

    Role of Growth Hormone Therapy in Metabolic-Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis by Deep Dutta, Lakshmi Nagendra, Ritin Mohindra, Saptarshi Bhattacharya, Ameya Joshi, ABM Kamrul-Hasan

    Published 2024-08-01
    “…Multiple observation studies and meta-analysis have linked growth hormone (GH) deficiency with metabolic-dysfunction-associated steatotic liver disease (MASLD). …”
    Get full text
    Article
  18. 1358
  19. 1359

    Comparative efficacy of different drugs in acute heart failure with renal dysfunction: a systematic review and network meta-analysis by Qianyu Lv, Qian Wu, Yingtian Yang, Lanlan Li, Xuejiao Ye, Shihan Wang, Yanfei Lv, Manshi Wang, Yushan Li

    Published 2025-01-01
    “…Hence, HDD and levosimendan may be optimal agents in the treatment of AHF with renal dysfunction.Systematic Review RegistrationPROSPERO, identifier (CRD42023454616).…”
    Get full text
    Article
  20. 1360

    Impaired microglial glycolysis promotes inflammatory responses after intracerebral haemorrhage via HK2-dependent mitochondrial dysfunction by Yin Li, Hang Zhou, Xuchao He, Lingji Jin, Yuhan Zhu, Libin Hu, Majing Feng, Jun Zhu, Liang Wang, Yonghe Zheng, Shiwei Li, Zhiyuan Yan, Peili Cen, Junwen Hu, Zihang Chen, Xiaobo Yu, Xiongjie Fu, Chaoran Xu, Shenglong Cao, Yang Cao, Gao Chen, Lin Wang

    Published 2025-07-01
    “…Results: Neurological dysfunction was strongly correlated with decreased FDG-PET signals in the perihaematomal region, where microglial uptake of FDG was reduced. …”
    Get full text
    Article